Ypsomed expands production facility in Schwerin

Press Releases Ypsomed Group

Burgdorf – Ypsomed (SIX: YPSN) is building a new production hall in Schwerin and creating 60 new jobs in the process. The company held the groundbreaking ceremony last Friday thus signaling the start of the construction for the 3300 square meters of additional production space, plus a further 1600 square meters for warehouse capacity and logistics. Digging work is scheduled to begin in June. The plant is expected to be operational following a construction phase of one year. The expansion will allow Ypsomed's site in Schwerin to produce more than 250 million infusion sets, pens and autoinjectors per year going forward.

Read more...

Go-ahead for a new Ypsomed production facility in China

Press Releases Ypsomed Group

Burgdorf – On 25 April 2023, the groundbreaking ceremony for Ypsomed's (SIX: YPSN) new production facility took place in the Changzhou National Hi-tech District. In order to be able to efficiently serve the rapidly growing Chinese market for injection systems, Ypsomed is investing over CHF 35 million in the new manufacturing plant in a first phase. Production is expected to commence in the second half of 2024.

Read more...

Sébastien Delarive to become new Senior Vice President Diabetes Care
Sébastien Delarive to become new Senior Vice President Diabetes Care.

Ypsomed focuses on growth and strengthens its business units

Press Releases Ypsomed Group

Burgdorf – With the aim of focusing on changing customer needs, Ypsomed is stepwise optimizing the organisation of the business units and the Management Board.

Read more...